MetaCap

Azora Therapeutics (AZR) vs Citius Oncology (CTOR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Azora Therapeutics is the larger company by market cap ($55.0 million vs $53.2 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AZR-24.51%CTOR-12.71%
+5%-14%-33%
Oct 28, 20261 yearNov 20, 2026
AZR+1.05%CTOR-9.12%
+8%-1%-10%
Oct 26, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AZR versus CTOR key metrics
MetricAZRCTOR
Share price$3.85$0.5035
Market cap$55.00M$53.25M
1-day change-0.52%-10.95%
YTD return—-49.65%
1-year return—-55.44%
EPS (TTM)$-18.09$-0.48
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-7.98M$-24.76M
52-week high$8.25$1.83
52-week low$1.31$0.491
Distance from 52-week high-53.33%-72.49%
Analyst consensus—none
Avg. price target upside—+694.44%
Average volume50.12K114.02K
Shares outstanding14.29M105.76M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Citius Oncology

CTOR stock →

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.

Health Care · Biotechnology: Pharmaceutical Preparations

AZR vs CTOR FAQ

Which is bigger, Azora Therapeutics or Citius Oncology?

Azora Therapeutics (AZR) is larger, with a market capitalization of $55.00M compared with $53.25M for Citius Oncology (CTOR).

Are Azora Therapeutics and Citius Oncology in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons